Clinical trial
Treatment of Coronary Atherosclerosis by Insulin Sensitizers in…
NCT00155350 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00155350 |
|---|---|
| Title | Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients |
| Official title | Treatment of Coronary Atherosclerosis and Calcification by Insulin Sensitizers in Insulin-Resistant Patients: Evaluated by EBCT, 16-Slice MDCT Coronary Angiography/Scanning, and Intravascular Ultrasound |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Atherosclerosis, Inflammation, Coronary Heart Disease |
| Intervention type | Drug |
| Interventions | pioglitazone |
| Enrollment | 120 |
| Start date | Nov 1, 2004 |
| Completion | Dec 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 27, 2006 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: